Ischemic stroke is one of the leading causes of mortality and morbidity in humans. During brain ischemia and the subsequent reperfusion that occurs with stroke, the generation of the so-called "proinflammatory" prostaglandin E 2 (PGE 2 ) increases significantly. Therefore, interest is growing regarding the differential functions of the individual PGE 2 receptors (EP1-4) and their relative contribution to brain damage following ischemic and inflammatory stimuli. Here, we address the contribution of the EP3 receptor in dictating early outcomes after transient cerebral ischemia. An oxygen-glucose deprivation (OGD)-induced in vitro model of brain ischemia was used in mouse hippocampal slice cultures. For transient ischemia, the right middle cerebral artery (MCA) of wildtype (WT) and EP3 knockout (EP3 −/− ) C57BL/6 male mice was occluded for 90 min and reperfused for 48 or 96 h, after which neurobehavioral scores and infarct volumes were determined. Mean arterial blood pressure, pH, blood gases (PaO 2 and PaCO 2 ), cerebral blood flow, and body temperature were also determined before and during ischemia and reperfusion. OGD-induced cell death was significantly lower in brain slice cultures of EP3 −/− mice than in those of WT mice. EP3 −/− mice that underwent transient ischemia had significantly smaller infarct volumes than did WT mice at 48 h, but this difference was not sustained at 96 h. Neurological score deficits correlated with infarct volume, but no significant differences in the physiological parameters monitored were detected between the two genotypes.
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The results further support a role for EP3 receptors in contributing to acute ischemic stroke, but EP3 is not likely the sole contributor to the long-term detrimental consequences of PGE 2 . © 2009 Elsevier B.V. All rights reserved.
Introduction
Increasing evidence indicates that oxidative stress and delayed inflammatory processes play a crucial role in ischemic-reperfusion (I/ R) injury. The generation of reactive oxygen species as a result of the early reperfusion period causes direct neurotoxic effects, including lipid peroxidation and oxidative protein and DNA damage (Muralikrishna Adibhatla and Hatcher, 2006). Brain damage may also occur as a result of increased free radical production during the post-reperfusion inflammatory response (Hoehn et al., 2005; Huang et al., 2006) . One determinant of inflammation-associated cytotoxicity is the increased expression of cyclooxygenase (COX)-2 (Iadecola and Gorelick, 2005; Kawano et al., 2006) . COX catalyzes the conversion of arachidonic acid to prostaglandin (PG) H 2 , after which, specific PG synthases metabolize PGH 2 to at least five structurally related bioactive lipid molecules, including PGE 2 , PGD 2 , PGF 2α , PGI 2 , and thromboxane A 2 (Doré, 2006; Wang et al., 2005) . Previous studies showed that COX-2-deficient mice and mice given COX-2 inhibitor had smaller infarct volumes after ischemic insult than did wildtype (WT) or vehicle-treated mice, respectively (Iadecola et al., 2001; Sugimoto and Iadecola, 2003) . Conversely, transgenic mice that overexpressed COX-2 had larger infarct volumes than did nontransgenic mice (Doré et al., 2003) .
It has been documented that PGE 2 mediates many, if not most, of the COX-2-induced neurotoxicity in inflammation and neurological disorders (Takadera and Ohyashiki, 2006) . PGE 2 exerts its cellular effects by binding primarily to high affinity receptors designated EP1 through EP4, which belong to the family of G-protein-coupled receptors. Stimulation of the EP1 receptor results in activation of phosphatidyl inositol hydrolysis and elevation of the intracellular Ca 2+ concentration (Ahmad et al., 2006a; Kawano et al., 2006) . EP2
and EP4 activation increases intracellular cyclic adenosine monophosphate (cAMP), whereas EP3 activation, in most instances, decreases it. EP3, like EP1, can mediate Ca 2+ flux and signaling (Audoly et al., 1999a) . Thus, the potential is great for variability in the response of target cells to PGE 2 based on which receptors it activates (Narumiya et al., 1999) . 
